Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Other Gross PP&E Adjustments (2016 - 2018)

Historic Other Gross PP&E Adjustments for Soleno Therapeutics (SLNO) over the last 6 years, with Q4 2018 value amounting to $35000.0.

  • Soleno Therapeutics' Other Gross PP&E Adjustments fell 4262.3% to $35000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $35000.0, marking a year-over-year decrease of 4262.3%. This contributed to the annual value of $35000.0 for FY2018, which is 4262.3% down from last year.
  • Per Soleno Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at $35000.0 for Q4 2018, which was down 4262.3% from $61000.0 recorded in Q4 2017.
  • Soleno Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $297595.0 for Q4 2015, and its period low was $35000.0 during Q4 2018.
  • Over the past 5 years, Soleno Therapeutics' median Other Gross PP&E Adjustments value was $131887.0 (recorded in 2014), while the average stood at $145981.3.
  • As far as peak fluctuations go, Soleno Therapeutics' Other Gross PP&E Adjustments soared by 3618.72% in 2015, and later crashed by 6893.43% in 2016.
  • Over the past 5 years, Soleno Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $218519.0 in 2014, then soared by 36.19% to $297595.0 in 2015, then tumbled by 68.93% to $92450.0 in 2016, then plummeted by 34.02% to $61000.0 in 2017, then crashed by 42.62% to $35000.0 in 2018.
  • Its Other Gross PP&E Adjustments was $35000.0 in Q4 2018, compared to $61000.0 in Q4 2017 and $92450.0 in Q4 2016.